ID   KS6A2_HUMAN             Reviewed;         733 AA.
AC   Q15349; Q15419; Q59GJ3; Q5TI68; Q96J38; Q9UJN5;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 2.
DT   05-OCT-2010, entry version 109.
DE   RecName: Full=Ribosomal protein S6 kinase alpha-2;
DE            Short=S6K-alpha-2;
DE            EC=2.7.11.1;
DE   AltName: Full=90 kDa ribosomal protein S6 kinase 2;
DE            Short=p90-RSK 2;
DE            Short=p90RSK2;
DE   AltName: Full=MAP kinase-activated protein kinase 1c;
DE            Short=MAPK-activated protein kinase 1c;
DE            Short=MAPKAP kinase 1c;
DE            Short=MAPKAPK-1c;
DE   AltName: Full=Ribosomal S6 kinase 3;
DE            Short=RSK-3;
DE   AltName: Full=pp90RSK3;
GN   Name=RPS6KA2; Synonyms=MAPKAPK1C, RSK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND SUBCELLULAR LOCATION.
RX   MEDLINE=95349602; PubMed=7623830;
RA   Zhao Y., Bjoerbaek C., Weremowicz S., Morton C.C., Moller D.E.;
RT   "RSK3 encodes a novel pp90rsk isoform with a unique N-terminal
RT   sequence: growth factor-stimulated kinase function and nuclear
RT   translocation.";
RL   Mol. Cell. Biol. 15:4353-4363(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-540 (ISOFORM 1).
RX   MEDLINE=94189676; PubMed=8141249;
RA   Moller D.E., Xia C.-H., Tang W., Zhu A.X., Jakubowski M.;
RT   "Human rsk isoforms: cloning and characterization of tissue-specific
RT   expression.";
RL   Am. J. Physiol. 266:C351-C359(1994).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [7]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-630, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RX   PubMed=17370265; DOI=10.1002/pmic.200600410;
RA   Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.;
RT   "Tryptic digestion of ubiquitin standards reveals an improved strategy
RT   for identifying ubiquitinated proteins by mass spectrometry.";
RL   Proteomics 7:868-874(2007).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-217; SER-218; SER-377
RP   AND SER-546, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-311 AND GLN-732.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine kinase that may play a role in
CC       mediating the growth-factor and stress induced activation of the
CC       transcription factor CREB.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by multiple phosphorylations on
CC       threonine and serine residues (By similarity).
CC   -!- SUBUNIT: Forms a complex with either ERK1 or ERK2 in quiescent
CC       cells. Transiently dissociates following mitogenic stimulation (By
CC       similarity).
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15349-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15349-2; Sequence=VSP_017732;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Expressed in many tissues. Highest expression
CC       in lung and skeletal muscle.
CC   -!- PTM: Autophosphorylated on Ser-377, as part of the activation
CC       process (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. S6 kinase subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 2 protein kinase domains.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC82496.1; Type=Erroneous initiation;
CC       Sequence=BAD92353.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X85106; CAA59427.1; -; mRNA.
DR   EMBL; AB209116; BAD92353.1; ALT_INIT; mRNA.
DR   EMBL; AL022069; CAI19651.1; -; Genomic_DNA.
DR   EMBL; Z98049; CAI19651.1; JOINED; Genomic_DNA.
DR   EMBL; Z98049; CAI20579.1; -; Genomic_DNA.
DR   EMBL; AL022069; CAI20579.1; JOINED; Genomic_DNA.
DR   EMBL; BC002363; AAH02363.1; -; mRNA.
DR   EMBL; L07598; AAC82496.1; ALT_INIT; mRNA.
DR   IPI; IPI00300321; -.
DR   IPI; IPI00478653; -.
DR   PIR; A57459; A57459.
DR   RefSeq; NP_001006933.1; -.
DR   RefSeq; NP_066958.2; -.
DR   UniGene; Hs.655277; -.
DR   UniGene; Hs.723857; -.
DR   ProteinModelPortal; Q15349; -.
DR   SMR; Q15349; 23-264, 50-337, 57-384, 410-704.
DR   DIP; DIP-295N; -.
DR   MINT; MINT-1542928; -.
DR   STRING; Q15349; -.
DR   PhosphoSite; Q15349; -.
DR   REPRODUCTION-2DPAGE; Q15349; -.
DR   PRIDE; Q15349; -.
DR   Ensembl; ENST00000265678; ENSP00000265678; ENSG00000071242.
DR   GeneID; 6196; -.
DR   KEGG; hsa:6196; -.
DR   UCSC; uc003qvb.1; human.
DR   UCSC; uc003qvd.1; human.
DR   CTD; 6196; -.
DR   GeneCards; GC06M166742; -.
DR   H-InvDB; HIX0006371; -.
DR   HGNC; HGNC:10431; RPS6KA2.
DR   HPA; CAB026243; -.
DR   MIM; 601685; gene.
DR   PharmGKB; PA34846; -.
DR   eggNOG; prNOG17810; -.
DR   HOVERGEN; HBG108317; -.
DR   OrthoDB; EOG9V45T5; -.
DR   PhylomeDB; Q15349; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_13685; Synaptic Transmission.
DR   Reactome; REACT_18266; Axon guidance.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 24063; -.
DR   ArrayExpress; Q15349; -.
DR   Bgee; Q15349; -.
DR   CleanEx; HS_RPS6KA2; -.
DR   Genevestigator; Q15349; -.
DR   GermOnline; ENSG00000071242; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR016239; Ribosomal_S6_kinase_II.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 2.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000606; Ribsml_S6_kin_2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 2.
DR   SUPFAM; SSF56112; Kinase_like; 2.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Isopeptide bond;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Repeat; Serine/threonine-protein kinase;
KW   Transferase; Ubl conjugation.
FT   CHAIN         1    733       Ribosomal protein S6 kinase alpha-2.
FT                                /FTId=PRO_0000086201.
FT   DOMAIN       59    318       Protein kinase 1.
FT   DOMAIN      319    388       AGC-kinase C-terminal.
FT   DOMAIN      415    672       Protein kinase 2.
FT   NP_BIND      65     73       ATP (By similarity).
FT   NP_BIND     421    429       ATP (By similarity).
FT   ACT_SITE    184    184       Proton acceptor (By similarity).
FT   ACT_SITE    532    532       Proton acceptor (By similarity).
FT   BINDING      91     91       ATP (By similarity).
FT   BINDING     444    444       ATP (By similarity).
FT   MOD_RES     217    217       Phosphotyrosine.
FT   MOD_RES     218    218       Phosphoserine.
FT   MOD_RES     356    356       Phosphothreonine (By similarity).
FT   MOD_RES     360    360       Phosphoserine (By similarity).
FT   MOD_RES     377    377       Phosphoserine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     546    546       Phosphoserine.
FT   MOD_RES     570    570       Phosphothreonine (By similarity).
FT   MOD_RES     730    730       Phosphoserine (By similarity).
FT   CROSSLNK    630    630       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT   VAR_SEQ       1     32       MDLSMKKFAVRRFFSVYLRRKSRSKSSSLSRL -> MPIAQ
FT                                LLELWKKIEVEPMEIETTEEDLNLDVGPATEDTAEEGKSDS
FT                                AACKTKVAGSV (in isoform 2).
FT                                /FTId=VSP_017732.
FT   VARIANT     311    311       E -> K (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_040627.
FT   VARIANT     732    732       R -> Q (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040628.
FT   CONFLICT    256    256       S -> A (in Ref. 5; AAC82496).
FT   CONFLICT    269    269       A -> S (in Ref. 5; AAC82496).
FT   CONFLICT    339    339       V -> L (in Ref. 1 and 5).
FT   CONFLICT    447    447       D -> G (in Ref. 5; AAC82496).
SQ   SEQUENCE   733 AA;  83239 MW;  087CFB819A313760 CRC64;
     MDLSMKKFAV RRFFSVYLRR KSRSKSSSLS RLEEEGVVKE IDISHHVKEG FEKADPSQFE
     LLKVLGQGSY GKVFLVRKVK GSDAGQLYAM KVLKKATLKV RDRVRSKMER DILAEVNHPF
     IVKLHYAFQT EGKLYLILDF LRGGDLFTRL SKEVMFTEED VKFYLAELAL ALDHLHSLGI
     IYRDLKPENI LLDEEGHIKI TDFGLSKEAI DHDKRAYSFC GTIEYMAPEV VNRRGHTQSA
     DWWSFGVLMF EMLTGSLPFQ GKDRKETMAL ILKAKLGMPQ FLSGEAQSLL RALFKRNPCN
     RLGAGIDGVE EIKRHPFFVT IDWNTLYRKE IKPPFKPAVG RPEDTFHFDP EFTARTPTDS
     PGVPPSANAH HLFRGFSFVA SSLIQEPSQQ DLHKVPVHPI VQQLHGNNIH FTDGYEIKED
     IGVGSYSVCK RCVHKATDTE YAVKIIDKSK RDPSEEIEIL LRYGQHPNII TLKDVYDDGK
     FVYLVMELMR GGELLDRILR QRYFSEREAS DVLCTITKTM DYLHSQGVVH RDLKPSNILY
     RDESGSPESI RVCDFGFAKQ LRAGNGLLMT PCYTANFVAP EVLKRQGYDA ACDIWSLGIL
     LYTMLAGFTP FANGPDDTPE EILARIGSGK YALSGGNWDS ISDAAKDVVS KMLHVDPHQR
     LTAMQVLKHP WVVNREYLSP NQLSRQDVHL VKGAMAATYF ALNRTPQAPR LEPVLSSNLA
     QRRGMKRLTS TRL
//
